| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 6.56% | 21.28% | -3.40% | -3.47% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 25.12% | 20.16% | 19.85% |
| Negative volatility | 15.66% | 14.77% | 13.56% |
| Sharpe | 0.84 | Neg | Neg |
| Sortino | 1.35 | Neg | Neg |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Selectra J. Lamarck Biotech A Cap EUR | 4.46% | -4.49% | -6.40% | -17.57% | 22.18% | 6.56% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |